LPL Financial Portfolio holdings
LPL Financial, founded in 1989 through the merger of Linsco and Private Ledger and headquartered in San Diego, California, is the largest independent broker-dealer in the U.S., supporting over 22,000 financial advisors who manage more than $1.4 trillion in advisory and brokerage assets as of late 2024. Serving independent advisors, banks, and credit unions, LPL provides a robust technology platform, research, and back-office support, enabling advisors to offer personalized wealth management, retirement planning, and investment services to clients without proprietary products. The firm, publicly traded since 2010 under CEO Dan Arnold, has grown through acquisitions like Waddell & Reed’s wealth management business in 2021, emphasizing flexibility and advisor autonomy. With additional offices in Fort Mill, South Carolina, and Boston, LPL Financial remains a leader in empowering advisors amid a shifting financial landscape.
Top Buys
| 1 |
Dimensional US Core Equity 2 ETF
DFAC
|
+$348M |
| 2 |
Health Care Select Sector SPDR Fund
XLV
|
+$247M |
| 3 |
iShares Gold Trust
IAU
|
+$219M |
| 4 |
iShares MSCI Emerging Markets Min Vol Factor ETF
EEMV
|
+$217M |
| 5 |
WisdomTree Floating Rate Treasury Fund
USFR
|
+$168M |
Top Sells
Sector Composition
| 1 | Technology | 5.66% |
| 2 | Healthcare | 3.17% |
| 3 | Financials | 3.02% |
| 4 | Consumer Discretionary | 2.48% |
| 5 | Industrials | 2.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
4176
Inseego
INSG
$202M
| $60K | ﹤0.01% |
3,152
+14
| +0.4% | +$266 |
|
4177
NatWest
NWG
$55.9B
| $60K | ﹤0.01% |
+10,291
| New | +$60K |
|
|
TRIB
4178
Trinity Biotech
TRIB
$4.43M
| $60K | ﹤0.01% |
9,750
-10,585
| -52% | -$65.1K |
|
4179
Momentus
MNTS
$14M
| $59K | ﹤0.01% |
+39
| New | +$59K |
|
4180
Cardiff Oncology
CRDF
$136M
| $58K | ﹤0.01% |
26,384
+3,998
| +18% | +$8.79K |
|
4181
indie Semiconductor
INDI
$721M
| $58K | ﹤0.01% |
+10,200
| New | +$58K |
|
|
MIN
4182
MFS Intermediate Income Trust
MIN
$305M
| $58K | ﹤0.01% |
19,487
-9,866
| -34% | -$29.4K |
|
4183
ASE Group
ASX
$24.9B
| $57K | ﹤0.01% |
10,938
-1,968
| -15% | -$10.3K |
|
4184
Evogene
EVGN
$10.3M
| $56K | ﹤0.01% |
7,254
-710
| -9% | -$5.48K |
|
|
INFN
4185
DELISTED
Infinera Corporation Common Stock
INFN
| $55K | ﹤0.01% |
10,180
-775
| -7% | -$4.19K |
|
4186
Archer Aviation
ACHR
$6.36B
| $54K | ﹤0.01% |
+17,543
| New | +$54K |
|
4187
Denison Mines
DNN
$2.39B
| $54K | ﹤0.01% |
55,379
-4,473
| -7% | -$4.36K |
|
4188
NGL Energy Partners
NGL
$848M
| $54K | ﹤0.01% |
35,807
-3,000
| -8% | -$4.52K |
|
4189
Opko Health
OPK
$1.15B
| $54K | ﹤0.01% |
21,536
-2,168
| -9% | -$5.44K |
|
4190
W&T Offshore
WTI
$261M
| $54K | ﹤0.01% |
12,447
-2,553
| -17% | -$11.1K |
|
|
RUBY
4191
DELISTED
Rubius Therapeutics, Inc
RUBY
| $54K | ﹤0.01% |
63,841
+13,689
| +27% | +$11.6K |
|
|
NMG
4192
Nouveau Monde Graphite
NMG
$346M
| $53K | ﹤0.01% |
+10,900
| New | +$53K |
|
4193
Clear Channel Outdoor Holdings
CCO
$696M
| $52K | ﹤0.01% |
48,860
-45,000
| -48% | -$47.9K |
|
|
FLNT
4194
Fluent
FLNT
$50.5M
| $52K | ﹤0.01% |
7,330
| – | – |
|
4195
Femasys
FEMY
$11.4M
| $51K | ﹤0.01% |
+21,032
| New | +$51K |
|
4196
Rekor Systems
REKR
$226M
| $51K | ﹤0.01% |
28,699
-50,300
| -64% | -$89.4K |
|
4197
CorMedix
CRMD
$836M
| $50K | ﹤0.01% |
12,323
| – | – |
|
4198
Lipocine
LPCN
$15.6M
| $50K | ﹤0.01% |
3,691
-441
| -11% | -$5.97K |
|
4199
TScan Therapeutics
TCRX
$102M
| $50K | ﹤0.01% |
+16,000
| New | +$50K |
|
|
GTHX
4200
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $50K | ﹤0.01% |
10,090
| – | – |
|